Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Intercept Pharmaceuticals Inc

+ Add to Watchlist


255.195 USD 0.835 0.33%

As of 20:10:00 ET on 05/29/2015.

Company Profile for Intercept Pharmaceuticals Inc (ICPT)

Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.

Contact Information

Intercept Pharmaceuticals Inc

450 West 15th Street
Suite 505
New York, NY 10011
United States
Phone: 1-646-747-1000
Fax: 1-646-747-1001

Key Executives for Intercept Pharmaceuticals Inc (ICPT)

Mark PruzanskiPresident/CEO/Co-FounderBarbara DuncanCFO/Treasurer/Secretary
Rachel L McMinnChief Strategy OfficerLuciano AdoriniChief Scientific Officer
David ShapiroExec VP:Dev/Chief Medical Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil